Contract facts
NONEDEVELOPING IN-007 AS A WIDELY DEPLOYABLE INHALED TREATMENT AGAINST PATHOGENS UTILIZING HUMAN ACE2 FOR VIRAL ATTACHMENT AND ENTRY is a federal NONE award for Army Med Res Acq Activity held by Inhalon Biopharma, Inc. Estimated value $2.2M ($2.2M obligated). Current period of performance ends Dec 22, 2026. Last award drew 47 bidders. Place of performance: MORRISVILLE NC. Related solicitation HT942523SJWMR.
DEVELOPING IN-007 AS A WIDELY DEPLOYABLE INHALED TREATMENT AGAINST PATHOGENS UTILIZING HUMAN ACE2 FOR VIRAL ATTACHMENT AND ENTRY
Recompete timing
PublicCurrent PoP ends Dec 22, 2026 (106 days remaining). Agencies typically plan 12–18 months ahead — at 3.5 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordInhalon Biopharma, Inc — $5.4M obligated across 2 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942524C0076?
HT942524C0076 (Developing in-007 as a WIDELY deployable) is a Army Med Res Acq Activity award with a potential value of $2.2M, currently held by Inhalon Biopharma, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9425-24-C-0076?
HT9425-24-C-0076 is the dashed form of PIID HT942524C0076 (Developing in-007 as a WIDELY deployable), held by Inhalon Biopharma, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT942524C0076?
Army Med Res Acq Activity awarded HT942524C0076 to Inhalon Biopharma, Inc (potential $2.2M).
Who is the incumbent on HT942524C0076?
Inhalon Biopharma, Inc is the incumbent with $5.4M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Dec 22, 2026.
When does Inhalon Biopharma, Inc’s HT942524C0076 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 22, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on HT942524C0076 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.